Next 10 |
home / stock / ipa / ipa articles
Immunoprecise Antibodies Ltd (NASDAQ:IPA), together with InterSystems, have collaborated to integrate the new vector search capability of the Int...
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-q...
ImmunoPrecise Antibodies (NASDAQ:IPA) ("IPA"), a leading company in AI-driven biotherapeutic research and technology, has recently provided an upda...
Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results. AeroVironment posted ad...
ImmunoPrecise Antibodies Ltd (NASDAQ: IPA) shares are trading lower by 23% to $1.19 Wednesday afternoon after the company announced pricing of...
U.S. stocks traded mostly flat midway through trading, with the S&P 500 turning lower on Wednesday. The Dow traded up 0.01% to 36,126.75 w...
U.S. stocks traded higher this morning, following the release of economic reports on Wednesday. Following the market opening Wednesday, the Dow tra...
Shares of SentinelOne, Inc. (NYSE: S) rose sharply in pre-market trading after the company reported stronger-than-expected results for its third q...
ImmunoPrecise Antibodies (NASDAQ: IPA) (“IPA”), a leading company in AI-driven biotherapeutic research and technology, has recently ann...
News, Short Squeeze, Breakout and More Instantly...
ImmunoPrecise Antibodies Ltd. Company Name:
IPA Stock Symbol:
NASDAQ Market:
Immunoprecise Antibodies Ltd (NASDAQ:IPA), together with InterSystems, have collaborated to integrate the new vector search capability of the Int...
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), InterSystems , a creative data technology provider dedicated to helping customers solve their most critical scalability, interoperability, and speed challenges, together with ImmunoPrecise ...
Significant throughput of LSA to advance IPA’s diversity- and data-driven drug development and to enrich LENS ai™ . IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an artificial intelligence-driven biotherapeuti...